This analysis examines PEPFAR spending and HIV viral suppression rates in 22 countries from 2018–2023 to help identify which investments most effectively drive HIV outcomes and inform future directions.
Which PEPFAR Investments Drive HIV Outcomes? Informing PEPFAR Transition and Scale-Down
